We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Crystal Structure of Transport Protein Links Structure to Function

By Biotechdaily staff writers
Posted on 15 Aug 2003
Researchers using advanced x-ray crystallography techniques have produced a high-resolution three-dimensional crystal structure for lactose permease, a member of the Major Facilitator Superfamily (MFS) of transport proteins.

Lactose permease is the primary mover of lactose through the membrane of Escherichia coli, and is a model for similar transport proteins in other organisms. More...
By applying the latest x-ray crystallography methods, investigators at Imperial College (London, UK; www.imperial.ac.uk) and the University of California, Los Angeles (USA; www.ucla.edu) have produced the crystal structure at 3.5 angstroms for the E coli lactose permease.

They reported in the August 1, 2003, issue of Science that the molecule was composed of N- and C-terminal domains, each with six transmembrane helices, symmetrically positioned within the permease. A large internal hydrophilic cavity open to the cytoplasmic side represented the inward-facing conformation of the transporter. The structure with a bound lactose homolog, beta-D-galactopyranosyl-1-thio-beta-D-galactopyranoside, revealed the sugar-binding site in the cavity, and residues that play major roles in substrate recognition and proton translocation were identified.

Senior author Professor So Iwata of the laboratory for membrane protein crystallography at Imperial College explained, "The three-dimensional structure of lactose permease gives us our first real picture of how the family of enzymes work. Membrane transport proteins play major roles in depression, stroke and diabetes. Unraveling their structure is critical not only for understanding how we function but also to improve drug design.”





Related Links:
Imperial College
University of California, Los Angeles

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
POC Immunoassay Analyzer
Procise DX
New
HIV-1 Molecular Diagnostic Assay
AltoStar HIV RT-PCR Kit 1.5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.